Shilajit D Kundu

  • 1972 Citations
19982021
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

My research focuses on strategies to diagnose and characterize bladder cancer, novel strategies to characterized prostate cancer aggressiveness, and prospectively studying quality of life outcomes in patients with urologic cancers.

I have successfully conducted and published on prospective evaluations of patients with urologic cancers including prostate, bladder, kidney and testicular cancer and have found that the impact of cancer treatment goes beyond physical limitations associated with treatment. My recent research aims to understand the complexities associated with patient expectations. This includes balancing factors associated with patient satisfaction including patient personality, physician-patient relationship, information-processing style, and a comforting experience with the health care environment. Dr. Kundu’s research focuses include treatment of bladder cancer, kidney cancer, urinary tract cancer, prostate cancer, robotic prostatectomy, robotic nephrectomy, and cancer genetics.

My clinical interests include bladder cancer, continent urinary diversions for bladder cancer, multimodal therapy for advanced cancers including surgical therapy for bladder cancer, prostate cancer, kidney cancer, testis cancer, robotic surgery for bladder cancer, and testis cancer treatment.

Certifications and Licenses

Urology

Training Experience

2007Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)
2009Fellowship, Memorial Sloan-Kettering Cancer Center

Education/Academic qualification

MD, University of Illinois - Chicago

… → 2001

Keywords

  • Bladder Cancer
  • Cancer Genetics
  • Kidney Cancer / Urinary Tract Cancer
  • Prostate Cancer
  • Robotic Nephrectomy
  • Robotic Prostatectomy

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 16 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Nephrectomy Medicine & Life Sciences
Transforming Growth Factors Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Prostate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2010 2021

Research Output 1998 2019

  • 1972 Citations
  • 55 Article
  • 3 Letter
  • 1 Short survey
  • 1 Review article
Prostatic Neoplasms
Anxiety
Therapeutics
1 Citation (Scopus)

Inflammatory Bowel Disease and the Risk of Prostate Cancer

Burns, J. A., Weiner, A. B., Catalona, W. J., Li, E. V., Schaeffer, E. M., Hanauer, S. B., Strong, S. A., Burns, J., Hussain, M. & Kundu, S. D., May 1 2019, In : European urology. 75, 5, p. 846-852 7 p.

Research output: Contribution to journalArticle

Inflammatory Bowel Diseases
Prostatic Neoplasms
Prostate-Specific Antigen
Safety Management
Incidence
1 Citation (Scopus)

Integrating PROMIS® computerized adaptive tests into a web-based intervention for prostate cancer

Fox, R. S., Moreno, P. I., Yanez, B., Estabrook, R., Thomas, J., Bouchard, L. C., McGinty, H. L., Mohr, D. C., Begale, M. J., Flury, S. C., Perry, K. T., Kundu, S. D. & Penedo, F. J., May 1 2019, In : Health Psychology. 38, 5, p. 403-409 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Anxiety
Hormones
Health Promotion
Tablets
1 Citation (Scopus)

Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer

Rimar, K. J., Glaser, A. P., Kundu, S. D., Schaeffer, E. M., Meeks, J. J. & Psutka, S. P., Jan 1 2018, In : Bladder Cancer. 4, 4, p. 411-418 8 p.

Research output: Contribution to journalArticle

Platinum
Urinary Bladder Neoplasms
Drug Therapy
Muscles
Cystectomy

Multi-institution analysis of racial disparity among African- American men eligible for prostate cancer active surveillance

Dinizo, M., Shih, W., Kwon, Y. S., Eun, D., Reese, A., Giusto, L., Trabulsi, E. J., Yuh, B., Ruel, N., Marchalik, D., Hwang, J., Kundu, S. D., Eggener, S. & Kim, I. Y., Apr 20 2018, In : Oncotarget. 9, 30, p. 21359-21365 7 p.

Research output: Contribution to journalArticle

African Americans
Prostatic Neoplasms
Prostatectomy
Tertiary Healthcare
Neoplasms